Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Children bear the greatest burden of climate-driven heat exposure

26

Aug 2026

Children bear the greatest burden of climate-driven heat exposure

New research by Vrije Universiteit Brussel (VUB) shows that globally up to 560 million children aged 0 to 9 years old (43% of all children in this age group) are living through at least one additional month (30 or more days) of heat stress per year due to human-induced climate change.

Breast milk fats may reflect more than the fats a mother eats

26

Aug 2026

Breast milk fats may reflect more than the fats a mother eats

A cross-sectional study of 109 breastfeeding women in the Netherlands found that maternal intakes of omega-3 and omega-6 PUFAs and trans fats were associated with corresponding fatty acid proportions in human milk. The researchers also identified links involving dietary fiber, diet quality and several micronutrients, although whether these relationships reflect direct biological effects or broader dietary patterns remains uncertain.

Tea, berries and dark chocolate featured in a diet linked to lower Parkinson’s risk

26

Aug 2026

Tea, berries and dark chocolate featured in a diet linked to lower Parkinson’s risk

A prospective UK Biobank study of 123,655 adults found that a dietary pattern richer in flavonoid-containing foods was modestly associated with a lower incidence of hospital-recorded Parkinson’s disease. The association was strongest among those with the highest flavonoid diet scores, while exploratory proteomic and transcriptomic analyses pointed to possible neuroimmune and cell-adhesion pathways but did not establish causality or mechanism.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.